1. Home
  2. ALVR vs LFVN Comparison

ALVR vs LFVN Comparison

Compare ALVR & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVR
  • LFVN
  • Stock Information
  • Founded
  • ALVR 2013
  • LFVN N/A
  • Country
  • ALVR United States
  • LFVN United States
  • Employees
  • ALVR N/A
  • LFVN N/A
  • Industry
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • LFVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALVR Health Care
  • LFVN Health Care
  • Exchange
  • ALVR Nasdaq
  • LFVN Nasdaq
  • Market Cap
  • ALVR 87.7M
  • LFVN 127.0M
  • IPO Year
  • ALVR 2020
  • LFVN N/A
  • Fundamental
  • Price
  • ALVR $0.94
  • LFVN $12.18
  • Analyst Decision
  • ALVR Sell
  • LFVN
  • Analyst Count
  • ALVR 5
  • LFVN 0
  • Target Price
  • ALVR $1.00
  • LFVN N/A
  • AVG Volume (30 Days)
  • ALVR 155.6K
  • LFVN 94.6K
  • Earning Date
  • ALVR 11-04-2024
  • LFVN 10-29-2024
  • Dividend Yield
  • ALVR N/A
  • LFVN 1.23%
  • EPS Growth
  • ALVR N/A
  • LFVN 15.00
  • EPS
  • ALVR N/A
  • LFVN 0.23
  • Revenue
  • ALVR N/A
  • LFVN $200,164,000.00
  • Revenue This Year
  • ALVR N/A
  • LFVN $4.36
  • Revenue Next Year
  • ALVR N/A
  • LFVN $3.85
  • P/E Ratio
  • ALVR N/A
  • LFVN $56.43
  • Revenue Growth
  • ALVR N/A
  • LFVN N/A
  • 52 Week Low
  • ALVR $0.58
  • LFVN $4.20
  • 52 Week High
  • ALVR $2.49
  • LFVN $14.71
  • Technical
  • Relative Strength Index (RSI)
  • ALVR 69.10
  • LFVN 51.31
  • Support Level
  • ALVR $0.74
  • LFVN $11.68
  • Resistance Level
  • ALVR $0.91
  • LFVN $14.71
  • Average True Range (ATR)
  • ALVR 0.06
  • LFVN 0.79
  • MACD
  • ALVR 0.01
  • LFVN -0.05
  • Stochastic Oscillator
  • ALVR 94.50
  • LFVN 19.04

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Share on Social Networks: